During the past decade, Penza Regional Clinical Hospital n.a. N.N. Burdenko conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 9 clinical trials were completed, i.e. on average, 128.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Penza Regional Clinical Hospital n.a. N.N. Burdenko" #1 sponsor was "Amgen" with 3 trials, followed by "Arena Pharmaceuticals" with 2 trials sponsored, "Bayer" with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Galapagos NV" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Penza Regional Clinical Hospital n.a. N.N. Burdenko" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Penza Regional Clinical Hospital n.a. N.N. Burdenko" are "Ulcerative Colitis" (4 trials), "Psoriatic Arthritis" (3 trials), "Angina Pectoris" (1 trials), "Coronary Artery Disease" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Penza Regional Clinical Hospital n.a. N.N. Burdenko" in a lesser frequency.

Most popular intervention types in "Penza Regional Clinical Hospital n.a. N.N. Burdenko" are "Drug" (12 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Etrasimod" (3 trials), "Apremilast 20mg" (2 trials), "Apremilast 30mg" (2 trials) and "Apremilast 30 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Penza Regional Clinical Hospital n.a. N.N. Burdenko" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Penza Regional Clinical Hospital n.a. N.N. Burdenko". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Penza Regional Clinical Hospital n.a. N.N. Burdenko, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Penza Regional Clinical Hospital n.a. N.N. Burdenko, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".